Replies to post #215856 on Biotech Values

[xavierprivas]

I don't know how outstanding shares are counted but in the 13G it looks
like TRIL has 13,146,239 Common Shares so the math is correct
as 2,173,000 sh is 16.5% of the above

https://www.sec.gov/Archives/edgar/data/1410830/000090266417004518/p17-2299sc13g.htm

Looking at the item 4 in the document

Item 4. OWNERSHIP.


The information required by Items 4(a) - (c) is set forth in Rows 5 - 11 of the cover page for each of the Reporting Persons and is incorporated herein by reference.

The Company informed the Reporting Persons in writing that as of December 5, 2017, there were 13,146,239 Common Shares outstanding. The percentages set forth herein are calculated based upon such number of outstanding Common Shares.

[rkrw]

It's not my number, it's TRIL's number. You can ask like I did, they're friendly.
They have some convertible preferred stock that's excluded from the new investors numbers even though it converts one for one. Designed to allow convert holders who may be >10% to work around reporting rules, that's why the new investor shows up as owning a larger percent than they really do (i'm assuming they aren't a convert holder).